Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 34 | 2024 | 17352 | 1.080 |
Why?
|
HIV-1 | 20 | 2024 | 6863 | 0.830 |
Why?
|
South Africa | 13 | 2024 | 1843 | 0.540 |
Why?
|
Vagina | 7 | 2024 | 838 | 0.540 |
Why?
|
Viral Load | 12 | 2024 | 3332 | 0.530 |
Why?
|
Lactobacillus | 5 | 2024 | 212 | 0.440 |
Why?
|
HIV | 4 | 2020 | 1582 | 0.440 |
Why?
|
Anti-Retroviral Agents | 7 | 2024 | 1784 | 0.420 |
Why?
|
Vaginosis, Bacterial | 2 | 2024 | 151 | 0.380 |
Why?
|
Anti-HIV Agents | 4 | 2024 | 4527 | 0.320 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2024 | 1351 | 0.290 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2024 | 2199 | 0.280 |
Why?
|
DNA, Viral | 2 | 2019 | 2202 | 0.250 |
Why?
|
Viremia | 4 | 2024 | 707 | 0.240 |
Why?
|
Genome, Viral | 2 | 2019 | 667 | 0.230 |
Why?
|
Nevirapine | 1 | 2004 | 273 | 0.220 |
Why?
|
Tuberculosis | 3 | 2011 | 2017 | 0.190 |
Why?
|
Academies and Institutes | 1 | 2023 | 318 | 0.190 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2022 | 369 | 0.170 |
Why?
|
Premature Birth | 2 | 2021 | 1782 | 0.160 |
Why?
|
Antitubercular Agents | 1 | 2007 | 1375 | 0.160 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2021 | 647 | 0.160 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2023 | 4580 | 0.160 |
Why?
|
CD4-Positive T-Lymphocytes | 8 | 2024 | 4369 | 0.160 |
Why?
|
Virus Replication | 3 | 2024 | 2435 | 0.150 |
Why?
|
Focus Groups | 1 | 2023 | 1413 | 0.140 |
Why?
|
Disclosure | 1 | 2023 | 748 | 0.140 |
Why?
|
Host-Pathogen Interactions | 4 | 2021 | 1459 | 0.140 |
Why?
|
HIV Antibodies | 2 | 2022 | 1303 | 0.140 |
Why?
|
Fatty Acids | 1 | 2024 | 1808 | 0.130 |
Why?
|
Immunity, Humoral | 1 | 2020 | 606 | 0.130 |
Why?
|
Qualitative Research | 2 | 2023 | 3023 | 0.130 |
Why?
|
Monocytes | 2 | 2021 | 2570 | 0.120 |
Why?
|
Metagenomics | 1 | 2019 | 467 | 0.120 |
Why?
|
Withholding Treatment | 1 | 2019 | 617 | 0.120 |
Why?
|
Contraceptive Agents, Female | 1 | 2015 | 118 | 0.120 |
Why?
|
Public Health | 1 | 2007 | 2669 | 0.120 |
Why?
|
Virus Latency | 1 | 2017 | 363 | 0.120 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2020 | 0.120 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1560 | 0.110 |
Why?
|
Antigens, CD | 2 | 2021 | 4001 | 0.110 |
Why?
|
Progestins | 1 | 2015 | 301 | 0.110 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2007 | 2151 | 0.110 |
Why?
|
Cervix Uteri | 1 | 2017 | 570 | 0.110 |
Why?
|
Interferon-gamma | 3 | 2019 | 3162 | 0.100 |
Why?
|
Cell Communication | 1 | 2020 | 1657 | 0.100 |
Why?
|
Th1 Cells | 1 | 2017 | 1036 | 0.100 |
Why?
|
Humans | 42 | 2024 | 761572 | 0.090 |
Why?
|
Female | 26 | 2024 | 392686 | 0.090 |
Why?
|
Evolution, Molecular | 1 | 2019 | 1886 | 0.090 |
Why?
|
Cytokines | 3 | 2021 | 7396 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2021 | 2747 | 0.090 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 2 | 2008 | 206 | 0.090 |
Why?
|
Immunoglobulin G | 1 | 2021 | 4544 | 0.080 |
Why?
|
Young Adult | 11 | 2021 | 59255 | 0.080 |
Why?
|
Lymphocyte Activation | 2 | 2020 | 5485 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2450 | 0.080 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2009 | 239 | 0.080 |
Why?
|
Lymphocytes | 1 | 2016 | 2612 | 0.070 |
Why?
|
Acute Disease | 4 | 2020 | 7237 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3801 | 0.070 |
Why?
|
DNA Methylation | 1 | 2021 | 4399 | 0.070 |
Why?
|
Intestines | 1 | 2016 | 1909 | 0.070 |
Why?
|
Poverty | 1 | 2018 | 2698 | 0.070 |
Why?
|
Public Sector | 1 | 2007 | 267 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7827 | 0.060 |
Why?
|
Longitudinal Studies | 5 | 2021 | 14607 | 0.060 |
Why?
|
Transcriptional Activation | 2 | 2023 | 1756 | 0.060 |
Why?
|
Infant, Newborn | 6 | 2024 | 26198 | 0.060 |
Why?
|
Health Plan Implementation | 1 | 2007 | 337 | 0.060 |
Why?
|
Oleic Acid | 1 | 2024 | 92 | 0.060 |
Why?
|
Self Care | 1 | 2009 | 796 | 0.060 |
Why?
|
Prospective Studies | 5 | 2024 | 54426 | 0.060 |
Why?
|
HLA Antigens | 1 | 2009 | 1328 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 2 | 2021 | 1844 | 0.060 |
Why?
|
HIV Long Terminal Repeat | 1 | 2023 | 85 | 0.050 |
Why?
|
Health Resources | 1 | 2009 | 935 | 0.050 |
Why?
|
Phylogeny | 2 | 2022 | 2811 | 0.050 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2023 | 119 | 0.050 |
Why?
|
Empirical Research | 1 | 2023 | 120 | 0.050 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2022 | 91 | 0.050 |
Why?
|
Pregnancy | 5 | 2024 | 29876 | 0.050 |
Why?
|
Receptors, CXCR5 | 1 | 2022 | 88 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10194 | 0.050 |
Why?
|
CD4 Lymphocyte Count | 3 | 2015 | 2571 | 0.050 |
Why?
|
Epitopes | 2 | 2022 | 2503 | 0.050 |
Why?
|
Killer Cells, Natural | 2 | 2020 | 2201 | 0.050 |
Why?
|
Genes, Immunoglobulin | 1 | 2021 | 285 | 0.050 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2023 | 439 | 0.050 |
Why?
|
Male | 9 | 2024 | 360842 | 0.050 |
Why?
|
Lymph Nodes | 2 | 2022 | 3466 | 0.050 |
Why?
|
Metronidazole | 1 | 2022 | 232 | 0.040 |
Why?
|
HIV Core Protein p24 | 1 | 2020 | 245 | 0.040 |
Why?
|
Acute-Phase Reaction | 1 | 2020 | 91 | 0.040 |
Why?
|
Adolescent | 8 | 2021 | 88324 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2021 | 470 | 0.040 |
Why?
|
Germinal Center | 1 | 2022 | 380 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1659 | 0.040 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 1 | 2019 | 50 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 1 | 2007 | 1802 | 0.040 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2021 | 898 | 0.040 |
Why?
|
Anti-Bacterial Agents | 2 | 2024 | 7407 | 0.040 |
Why?
|
Phenotype | 3 | 2023 | 16592 | 0.040 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2007 | 1897 | 0.040 |
Why?
|
RNA, Viral | 2 | 2019 | 2846 | 0.040 |
Why?
|
HIV Envelope Protein gp41 | 1 | 2020 | 303 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2020 | 1060 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2021 | 585 | 0.040 |
Why?
|
Systems Integration | 1 | 2020 | 426 | 0.040 |
Why?
|
Gender Identity | 1 | 2024 | 766 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2021 | 964 | 0.040 |
Why?
|
Violence | 1 | 2024 | 936 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4575 | 0.040 |
Why?
|
Glycosylation | 1 | 2020 | 1097 | 0.040 |
Why?
|
Complement System Proteins | 1 | 2020 | 735 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 891 | 0.040 |
Why?
|
Prevotella | 1 | 2017 | 80 | 0.030 |
Why?
|
Bacteria, Anaerobic | 1 | 2017 | 70 | 0.030 |
Why?
|
Time Factors | 4 | 2021 | 39970 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2023 | 4352 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2021 | 18965 | 0.030 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2020 | 914 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3639 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2017 | 5869 | 0.030 |
Why?
|
Antigens, Viral | 1 | 2019 | 988 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2015 | 240 | 0.030 |
Why?
|
Phagocytosis | 1 | 2020 | 1528 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2010 | 8002 | 0.030 |
Why?
|
Women's Health | 1 | 2024 | 2065 | 0.030 |
Why?
|
Cohort Studies | 4 | 2018 | 41493 | 0.030 |
Why?
|
Africa | 1 | 2015 | 709 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1784 | 0.030 |
Why?
|
Peer Group | 1 | 2018 | 692 | 0.030 |
Why?
|
Injections | 1 | 2015 | 831 | 0.030 |
Why?
|
Medication Adherence | 1 | 2024 | 2176 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2019 | 1359 | 0.030 |
Why?
|
Biodiversity | 1 | 2015 | 347 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 1974 | 0.030 |
Why?
|
Contraception | 1 | 2015 | 349 | 0.030 |
Why?
|
Glucose | 1 | 2024 | 4346 | 0.020 |
Why?
|
Infant | 4 | 2024 | 36192 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2009 | 5440 | 0.020 |
Why?
|
Health Education | 1 | 2018 | 1052 | 0.020 |
Why?
|
Biopsy | 1 | 2023 | 6766 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1745 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2021 | 4243 | 0.020 |
Why?
|
Adult | 7 | 2020 | 221203 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2015 | 1039 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2024 | 3847 | 0.020 |
Why?
|
Therapeutic Equipoise | 1 | 2010 | 28 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4111 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6864 | 0.020 |
Why?
|
Immune Reconstitution Inflammatory Syndrome | 1 | 2010 | 61 | 0.020 |
Why?
|
Laboratories, Hospital | 1 | 2011 | 192 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29629 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26127 | 0.020 |
Why?
|
Apoptosis | 2 | 2016 | 9489 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2004 | 14666 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2023 | 7593 | 0.020 |
Why?
|
Sputum | 1 | 2011 | 506 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6312 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1406 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2019 | 10448 | 0.020 |
Why?
|
Gene Products, gag | 1 | 2009 | 312 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2022 | 4758 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3080 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8633 | 0.020 |
Why?
|
HLA-B Antigens | 1 | 2009 | 317 | 0.020 |
Why?
|
pol Gene Products, Human Immunodeficiency Virus | 1 | 2007 | 39 | 0.020 |
Why?
|
Genetic Variation | 1 | 2023 | 6567 | 0.020 |
Why?
|
Kinetics | 1 | 2015 | 6374 | 0.020 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2007 | 148 | 0.020 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2010 | 662 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2011 | 746 | 0.020 |
Why?
|
Africa South of the Sahara | 1 | 2007 | 744 | 0.010 |
Why?
|
Bacteria | 1 | 2015 | 2199 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9420 | 0.010 |
Why?
|
Interferons | 1 | 2007 | 706 | 0.010 |
Why?
|
Cell Movement | 1 | 2016 | 5205 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2016 | 3066 | 0.010 |
Why?
|
Risk | 1 | 2015 | 9610 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2016 | 3060 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22176 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4853 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 64684 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10773 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2019 | 11530 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42230 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12463 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2008 | 1889 | 0.010 |
Why?
|
Child | 2 | 2024 | 80156 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9319 | 0.010 |
Why?
|
Developing Countries | 1 | 2011 | 2885 | 0.010 |
Why?
|
Mothers | 1 | 2009 | 2198 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11904 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39107 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21355 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10553 | 0.010 |
Why?
|
United States | 1 | 2023 | 72335 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30054 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2011 | 5336 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13510 | 0.010 |
Why?
|
Animals | 2 | 2017 | 168467 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81533 | 0.010 |
Why?
|
Middle Aged | 1 | 2017 | 220920 | 0.000 |
Why?
|
Concepts
(205)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_